Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial

2014 ◽  
Vol 191 (6) ◽  
pp. 1721-1727 ◽  
Author(s):  
Teresa L. Kauf ◽  
Robert S. Svatek ◽  
Gilad Amiel ◽  
Timothy L. Beard ◽  
Sam S. Chang ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Economic Analysis ◽  
Receptor Antagonist ◽  
Radical Cystectomy ◽  
Opioid Receptor ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Opioid Receptor Antagonist ◽  
Μ Opioid Receptor ◽  
Reduced Costs

Nutritional Intervention and Health-Related Quality of Life in Patients Undergoing Radical Cystectomy - A Randomized Controlled Trial

2021 ◽  
Vol 41 (4) ◽  
pp. 179
Author(s):  
Anja Kort ◽  
Line Noes Lydom ◽  
Lisbeth Nerstrom Salling ◽  
Susanne Vahr Lauridsen ◽  
Bente Appel Esbensen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Randomized Controlled Trial ◽  
Radical Cystectomy ◽  
Controlled Trial ◽  
Nutritional Intervention ◽  
Health Related Quality ◽  
Randomized Controlled ◽  
Related Quality ◽  
Health Related

Pharmacological Profile of Naldemedine, a Peripheral Acting μ-Opioid Receptor Antagonist: Comparison With Naloxone and Naloxegol

2018 ◽  
Vol 113 (Supplement) ◽  
pp. S96-S97
Author(s):  
Toshiyuki Kanemasa ◽  
Katsumi Koike ◽  
Kenji Takase ◽  
Tohko Arai ◽  
Atsushi Nakamura ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Opioid Receptor ◽  
Pharmacological Profile ◽  
Opioid Receptor Antagonist ◽  
Μ Opioid Receptor

Multimodal Prehabilitation to Enhance Functional Capacity Following Radical Cystectomy: A Randomized Controlled Trial

2019 ◽  
Author(s):  
Enrico Maria Minnella ◽  
Rashami Awasthi ◽  
Guillaume Bousquet-Dion ◽  
Vanessa Ferreira ◽  
Berson Austin ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Radical Cystectomy ◽  
Functional Capacity ◽  
Controlled Trial ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document